Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03687931 · ClinicalTrials.gov registry record · Phase 1
A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery
A Phase 1 study of Inflammation Eye, sponsored by iDrop.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03687931: Completed Phase 1 study of Inflammation Eye, sponsored by iDrop.
NCT03687931 is a Phase 1 study of Inflammation Eye that has completed, run by iDrop. The registered enrollment target is 60 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03687931, a Phase 1 study of Inflammation Eye, has completed, sponsored by iDrop.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of two dose levels of dexamethasone ophthalmic suspension eye drops to determine if the drops decrease inflammation inside the eye and are safe after cataract surgery.
Primary Outcome
Number of cells in the anterior chamber
Conditions Studied
Interventions
- DRUG Dexamethasone
Study Locations (1)
Arizona
- Arizona Eye Center - Chandler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-08-26 |
| Est. Completion | 2019-02-28 |
| Phase | Phase 1 |
What the finished NCT03687931 record still lists
NCT03687931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 1 condition, with Inflammation Eye appearing as the primary indexed condition, and to 1 intervention - of which Dexamethasone is the first listed.
NCT03687931 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT03687931 about?
NCT03687931 is a clinical study titled "A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery". Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of two dose levels of dexamethasone ophthalmic suspension eye drops to determine if the drops decrease inflammation inside the eye and are safe after cataract surgery.
What is the current status of trial NCT03687931?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2018-08-26. Estimated completion is 2019-02-28.
What conditions does trial NCT03687931 study?
This clinical trial studies the following conditions: Inflammation Eye.
What interventions are being tested in trial NCT03687931?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT03687931?
This trial is sponsored by iDrop, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03687931 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03687931's enrollment target sits among peer trials
60 831st of 2000 higher than 1,106 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI